Pictet Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Pictet Asset Management's NVO Position: Q2 2026 in Review
Pictet Asset Management reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $3.8M and leaving 395,861 shares worth $19M. The position accounts for 0.02% of the portfolio, ranked #541.
Pictet Asset Management first reported a position in NVO in Q4 2023 and has held it in 6 quarters since. The position peaked at $31.2M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Pictet Asset Management held 395,861 shares of Novo Nordisk worth $19M as of Q2 2026.
- Pictet Asset Management sold 88,489 Novo Nordisk shares in Q2 2026, an estimated $3.8M.
- Novo Nordisk made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #541 holding.
- Pictet Asset Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 6 quarters since.
- Pictet Asset Management's Novo Nordisk position peaked at $31.2M in Q1 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.